Literature DB >> 21999503

Axis IV psychosocial problems among patients with psychotic or mood disorders with a cannabis use disorder comorbidity.

Michael T Compton1, Chantelle M Simmons, Paul S Weiss, Joyce C West.   

Abstract

Among 1,610 patients with psychotic or mood disorders in routine psychiatric practice, odds ratios (crude and adjusted for age, education, gender, and race) quantified associations between the presence of comorbid cannabis abuse/dependence and seven psychosocial problems. Results revealed a higher prevalence of five of seven Axis IV psychosocial problems among patients who had a psychotic or mood disorder and a comorbid cannabis use disorder. The results underscore the need for careful screening and treatment of comorbid cannabis abuse/dependence among patients with psychotic or mood disorders given the prominent associated psychosocial impairments in this population.
Copyright © American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Year:  2011        PMID: 21999503     DOI: 10.1111/j.1521-0391.2011.00184.x

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  3 in total

1.  The association of specific traumatic experiences with cannabis initiation and transition to problem use: Differences between African-American and European-American women.

Authors:  K B Werner; V V McCutcheon; A Agrawal; C E Sartor; E C Nelson; A C Heath; K K Bucholz
Journal:  Drug Alcohol Depend       Date:  2016-03-08       Impact factor: 4.492

2.  Prevalence and clinical correlates of substance use disorders in South African Xhosa patients with schizophrenia.

Authors:  Henk Temmingh; Ezra Susser; Sumaya Mall; Megan Campbell; Goodman Sibeko; Dan J Stein
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2020-08-14       Impact factor: 4.328

3.  American counselors' acceptance of non-abstinence outcome goals for clients diagnosed with co-occurring substance use and other psychiatric disorders.

Authors:  Alan K Davis; Harold Rosenberg; Joseph A Rosansky
Journal:  J Subst Abuse Treat       Date:  2017-08-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.